Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
Journal: Annals of the rheumatic diseases
Published: September 02, 2016
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).
Journal: Annals of the rheumatic diseases
Published: August 09, 2013
Showing 1-2 of 2
Last Updated: 09/26/2026